Cholesterol; Lipidosis, High Density Lipoprotein Deficiency, LDL - Low Density Lipoprotein Receptor Disorder, Motivational Interview, Self Efficacy, Self Management, Tele-nursing, Type2 Diabetes
Conditions
Brief summary
This study carried out to examine the effect of tele-nursing based motivational interviewing on diabetes self-efficacy, diabetes self-management and metabolic control parameters (Body mass index, waist circumference, HbA1c%,fasting blood glucose, LDL cholesterol, HDL cholesterol, total cholesterol, triglyceride) in individuals with type 2 diabetes.
Detailed description
The first researcher of the article who applied Motivational Interviewing Techniques has a Motivational Interviewing Techniques Training certificate. A motivational interview (MI) program based on the telenursing approach was prepared by the researchers based on the literature for the individuals in the experimental group. In this study, the MI procedure includes eight sessions in total, with four sessions of motivational interviews by phone in the first month of the intervention and four sessions of motivational interviews by phone in the next two months for each individual. Pre-tests were collected in the first month. Afterwards, MI intervention was applied for three months. This intervention was applied to the experimental group in addition to the routine care provided by the hospital. MI application took an average of 45-60 minutes via phone call.
Interventions
A motivational interview (MI) program based on the telenursing approach was applied to the individuals in the experimental group. In this study, the MI procedure includes eight sessions in total, with four sessions of motivational interviews by phone in the first month of the intervention and four sessions of motivational interviews by phone in the next two months for each individual. Pre-tests were collected in the first month. Afterwards, MI intervention was applied for three months. This intervention was applied to the experimental group in addition to the routine care provided by the hospital. MI application took an average of 45-60 minutes via phone call.
Sponsors
Study design
Masking description
Single blinding was provided that included inclusion criteria and agreement to participate in the study.
Intervention model description
This study is a parallel group randomized controlled study.
Eligibility
Inclusion criteria
1\) being over 18 years old, 2) receiving insulin or insulin + oral therapy, 3) diagnosis of type 2 diabetes at least one year ago, 4) having a BMI of 25 and above, 5) HbA1c value of 7 and above, 6) access to phone, 7) voluntarily agreeing to participate in the study.
Exclusion criteria
1\) have a physical disability.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Diabetes Self-Efficacy Scale | Change from Baseline diabetes self-efficacy at 6 months | The change in diabetes self efficacy of individuals with Type 2 diabetes at 3rd month and 6 rd month with the Diabetes Self-Efficacy Scale. |
| Diabetes Self-Management Scale | Change from Baseline diabetes self-management at 6 months | This scale was used to measure the behavioral component of individuals in the IMB model. The validity and reliability study of the Turkish Diabetes Self-Management Perception Scale was conducted by Eroğlu and Sabuncu (2018). The scale consists of 16 items and 4 sub-dimensions and is a 4-point Likert type. Glucose Management sub-dimension: Items 4, 6, 10, 12 (items 4 and 12 are about drug use, items 1, 6 and 10 are about blood glucose monitoring). Diet Control sub-dimension: Items 2, 5, 9, 13. Physical Activity sub-dimension: Items 8, 11, 15. Use of Health Services sub-dimension: It consists of 3, 7, 14, and 16 items. The DMS scale consists of 16 items, 7 of which are straight and 9 of which are reversed. The scores of the items numbered 5, 7, 10, 11, 12, 13, 14, 15 and 16 in the scale are calculated by reversing them. Diabetes self-management increases as the score gets closer to 10. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| FBG | Change from Baseline Fasting glucose at 6 months | Fasting blood glucose |
| LDL | Change from Baseline LDL at 6 months | Low-density lipoprotein |
| HDL | Change from Baseline HDL at 6 months | High-density lipoprotein |
| HbA1c% | Change from Baseline HbA1c% at 6 months | Hemoglobin A1C |
| Total cholesterol | Change from Baseline total cholesterol at 6 months | Total cholesterol |
| Triglyceride | Change from Baseline total triglyceride at 6 months | triglyceride |
| waist circumference | Change from Baseline waist circumference at 6 months | waist circumference |
| BMI | Change from Baseline Body Mass Index at 6 months | Body Mass Index |
Countries
Turkey (Türkiye)